DIANA MULLIS: Open Payments
NPI 1629186663 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 10 payments from 7 companies in 2025. Trend: 2023 $1,112 · 2024 $506 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $248 |
| E.R. Squibb & Sons, L.L.C. | 2 | $233 |
| Janssen Scientific Affairs, LLC | 2 | $128 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| Alkermes, Inc. | 1 | $110 |
| Neurocrine BioSciences, Inc. | 1 | $108 |
| Janssen Pharmaceuticals, Inc | 1 | $89 |
Products named: COBENFY, INVEGA SUSTENNA, Auvelity, UZEDY, ARISTADA, INGREZZA, SPRAVATO.
Industry payments across SC — which companies pay providers there.
